Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms.
about
The phosphate regulon and bacterial virulence: a regulatory network connecting phosphate homeostasis and pathogenesisProbing the nucleotide binding and phosphorylation by the histidine kinase of a novel three-protein two-component system from Mycobacterium tuberculosisCharacterization of the mrgRS locus of the opportunistic pathogen Burkholderia pseudomallei: temperature regulates the expression of a two-component signal transduction systemToxin production in a rare and genetically remote cluster of strains of the Bacillus cereus group.A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinasesThiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis.DevR (DosR) mimetic peptides impair transcriptional regulation and survival of Mycobacterium tuberculosis under hypoxia by inhibiting the autokinase activity of DevS sensor kinase.Predicting the fission yeast protein interaction network.Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios.Essential genes in Bacillus subtilis: a re-evaluation after ten years.Role of the PAS sensor domains in the Bacillus subtilis sporulation kinase KinA.VirR-Mediated Resistance of Listeria monocytogenes against Food Antimicrobials and Cross-Protection Induced by Exposure to Organic Acid Salts.Emerging roles for protein histidine phosphorylation in cellular signal transduction: lessons from the islet beta-cell.Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.Bacterial sensor kinase TodS interacts with agonistic and antagonistic signals.Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.Bacterial response regulators: versatile regulatory strategies from common domains.Structural analysis and solution studies of the activated regulatory domain of the response regulator ArcA: a symmetric dimer mediated by the alpha4-beta5-alpha5 face.The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.Probing the roles of the two different dimers mediated by the receiver domain of the response regulator PhoB.Microcalorimetry: a response to challenges in modern biotechnology.Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections.Bacterial signal transduction networks via connectors and development of the inhibitors as alternative antibiotics.Comparative genomic assessment of novel broad-spectrum targets for antibacterial drugs.New class of competitive inhibitor of bacterial histidine kinases.Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalKEssentiality, bypass, and targeting of the YycFG (VicRK) two-component regulatory system in gram-positive bacteria.Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production.Novel antibacterial compounds specifically targeting the essential WalR response regulator.Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent.Teaching old drugs new tricks: Addressing resistance in Francisella.Retrospective evaluation of a possible interaction between warfarin and levofloxacin.The role of the CroR response regulator in resistance of Enterococcus faecalis to D-cycloserine is defined using an inducible receiver domain.Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies.The VicRK system of Streptococcus mutans responds to oxidative stress.
P2860
Q28267290-B10DFE83-306B-4ABB-9788-E3149414BD0DQ28486599-D9F805CC-8B35-4055-B7C7-5C9E58C21BAEQ33253132-CE181718-7675-4143-9250-C0489D76A463Q33285301-4FDFAE94-C561-4B10-81CA-95B08CC9C876Q33738068-FC0D039C-884E-430F-861D-9A36871CEA72Q33828707-71C9C437-EBF1-4820-BB18-1008967C47F5Q33946287-929A98AE-5219-46BC-A17B-A0961B6441BFQ34271399-90B4FD39-14AE-45A6-AEAC-C65A49AAF913Q34325509-199D7F3F-5FA4-4016-99E4-B012B76AAFFCQ34328444-E2F0C9B6-64E9-4F38-8E66-B5254E59F87BQ34624767-EFD0B5BA-CFFF-43B9-A178-2C948C281E29Q35764084-EFED2E6E-00D6-4D2F-B323-D42AAA777B0CQ35862451-D664206C-424E-4DD5-8CBB-153A94725C6AQ35878781-CF1FBFB2-F4DA-41AB-9F91-532C98FF77FCQ35963037-62DD6355-EAFF-4266-9EAA-06E64649F24BQ36211098-77D966C2-CB14-48F0-A222-1915987A2EA6Q36791337-B95D591D-2E62-41CD-8B6B-E8E39EF94A01Q36949989-0CE12EC8-4F5E-4121-950F-8883D0BD13CEQ36956080-6CC96DE0-E2F5-4A85-8EA0-60D5C5837814Q37276243-F34808FA-6406-4D19-BAB2-9D9400576799Q37395452-405FE961-6A3E-4B40-8D99-83F13708B9BBQ37590383-600A7452-108D-4C85-8D71-41387440B1F6Q39457826-18F9E696-C451-4C06-9FE4-64AB33196EA9Q39776959-2981D32E-A370-496D-B4A5-0EAB3260BF8EQ39892463-B83677CA-585F-4D35-919A-1BEED8B35F6CQ41811635-7622F5E2-0F72-4304-8EAE-3B4E2459CD8CQ42143639-50CB4CDD-84FC-459E-8AAD-8092BA6573ABQ42688761-B6A05696-F368-4FD3-871C-924716B5CA61Q43181262-D93A14A7-F884-4C61-8CCA-4CDB3E2FBC6EQ43207922-FAA155EF-ED29-4A50-AE29-CA31BB1E3560Q43226628-1690D8A6-9C35-4969-B47F-53A554B6082FQ46378368-B0769533-1A90-4D04-82CB-6271F43B270DQ47330349-1CE05AB0-C686-4528-8CF7-5A934A532BA9Q48371459-A88419F2-7698-45C4-A4CB-39CE2484BD4AQ50675805-67BF09A8-1CF0-4592-9FA3-100454E09595
P2860
Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Developing inhibitors to selec ...... of pathogenic microorganisms.
@ast
Developing inhibitors to selec ...... of pathogenic microorganisms.
@en
type
label
Developing inhibitors to selec ...... of pathogenic microorganisms.
@ast
Developing inhibitors to selec ...... of pathogenic microorganisms.
@en
prefLabel
Developing inhibitors to selec ...... of pathogenic microorganisms.
@ast
Developing inhibitors to selec ...... of pathogenic microorganisms.
@en
P356
P1476
Developing inhibitors to selec ...... of pathogenic microorganisms.
@en
P2093
K Stephenson
P304
P356
10.2174/0929867043455765
P577
2004-03-01T00:00:00Z